Diseases, Conditions, Syndromes

New COVID variant may be less threatening than first feared

When new COVID variant BA.2.86 emerged in late July, scientists had concerns about its ability to evade immunity. But early lab tests seem to be easing those fears, as well as concerns over the variant's ability to spread ...

Ophthalmology

IOP spikes common after cyclophotocoagulation

(HealthDay)—For patients undergoing cyclophotocoagulation, intraocular pressure (IOP) spikes are common in the immediate postoperative period, according to a study published in the December issue of Clinical & Experimental ...

Medications

EU regulator advises AstraZeneca's COVID drug be cleared

The European Union's drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.

Diseases, Conditions, Syndromes

Lab boost for precious anti-malaria drug

US scientists on Wednesday said they had used baker's yeast to make a key ingredient of malaria drugs, a feat that could iron out fluctuations in supply caused by sourcing the chemical from a Chinese herb.

page 18 from 21